Intocell Inc (287840)

Currency in KRW
23,000
+1,000(+4.55%)
Closed·
287840 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
20,80023,000
52 wk Range
20,20074,900
Key Statistics
Bid/Ask
23,000.00 / 23,050.00
Prev. Close
23,000
Open
22,300
Day's Range
20,800-23,000
52 wk Range
20,200-74,900
Volume
44.88K
Average Volume (3m)
75.67K
1-Year Change
-43.2099%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
287840 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
15-05-2026
EPS / Forecast
-267.00 / --
Revenue / Forecast
281.15M / --
EPS Revisions
Last 90 days

287840 Income Statement

Compare 287840 to Peers and Sector

Metrics to compare
287840
Peers
Sector
Relationship
P/E Ratio
−29.4x−22.8x−0.4x
PEG Ratio
2.25−0.390.00
Price/Book
15.5x2.0x2.6x
Price / LTM Sales
133.7x8.0x3.0x
Upside (Analyst Target)
-0.0%49.1%
Fair Value Upside
Unlock18.9%6.3%Unlock

IntoCell, Inc. develops protein-drug conjugates for the treatment of cancer. It develops antibody drug conjugates (ADC), fusion albumin drug conjugates, and triple conjugates. The company also develops B7-H3 ADC, which is in preclinical Phase for the treatment of solid cancers, as well as HER3 ADC, 5T4 ADC, and PSMA ADC for solid cancers. In addition, it develops Ortho-Hydroxy Protected Aryl Sulfate (OHPAS), a novel self-immolative group that designs to incorporate various functional groups for linking targeting moieties; and OHPASM Linker-toxin Library, an optimized linker-toxin library for fast delivery of a pre-clinical candidate in novel ADC programs. The company was founded in 2015 and is based in Daejeon, South Korea.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
360.000.00%7.92M
Other Institutional Investors
2.97M19.78%65.36B
Public Companies & Retail Investors
12.05M80.22%265.12B
Total
15.02M100.00%330.48B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Orbit-Brave New Technology Fund 14.74%7,11,5871,56,54,914
Brave New Investment4.74%7,11,5871,56,54,914

FAQ

What Is the Intocell (287840) Share Price Today?

The Intocell share price today is 23,000.

What is the current Intocell (287840) share price and day range?

As of 06-07-2026, the Intocell share price is 23,000, with a previous close of 23,000. The share price has ranged from 20,800 to 23,000 today, while the 52-week range spans from 20,200 to 74,900.

What Is the Intocell Market Cap?

As of today, Intocell market cap is 345.51B.

What Is Intocell's Earnings Per Share (TTM)?

The Intocell EPS (TTM) is -765.

From a Technical Analysis Perspective, Is 287840 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

What Stock Exchange Does Intocell Trade On?

Intocell is listed and trades on the KOSDAQ.

What Is the Stock Symbol for Intocell?

The stock symbol for Intocell is "287840."

How Many Times Has Intocell Stock Split?

Intocell has split 0 times.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.